Curative Biotechnology Faces Financial Crisis: Stock Plummets, Negative P/E Sparks Investor Alarm
Curative Biotechnology Inc. faces steep stock decline, a negative P/E ratio, and liquidity concerns, raising red flags for investors and highlighting the risks of small biotech firms.
2 minutes to read
